Delivery Order SPE2DB22D1106-SPE2DB25FESV4

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $40,477.39. The contract is a Firm Fixed Price arrangement and has an ultimate completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,926.49 firm fixed-price contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a medication, with a ceiling value of $34,483.75 and a performance period through May 21, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML, a pharmaceutical product, with a ceiling value of $3,570.63 and a performance period through May 29, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,160.54 firm fixed-price contract is for the supply of ORENCIA 250 MG VIALS, a pharmaceutical product. The delivery order has a completion date of June 11, 2025. Amerisourcebergen Drug Corp is the prime contractor, and this award is not set-aside. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $10,470.71. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,812.07, is for the delivery of ORENCIA CL 125MG/ML 4S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a $14,282.52 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through May 13, 2025. There is no set-aside designation for this contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,351.94 Firm Fixed Price delivery order contract is for the supply of ORENCIA 125 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of June 28, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ORENCIA 125 MG/ML SYRINGES. The $40,976.29 fixed-price contract has a period of performance through September 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FESV4
    Delivery Order

This is a delivery order federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $17,334.93, and an ultimate completion date of June 11, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract allows Amerisourcebergen to supply a range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/9/25, 12:58 PM